<DOC>
	<DOCNO>NCT01293903</DOCNO>
	<brief_summary>The pathogenesis dilate cardiomyopathy ( DCM ) lead heart failure closely associate autoimmunity dysfunction . A study represent Qiliqiangxin capsule , Chinese medicine , could enhance heart function chronic heart failure regulate balance TNF-a IL-10 myocardial infarction . In study , explore effect Qiliqiangxin capsule improve heart function immunoregulation patient DCM , patient recruit , anti-heart autoantibody representative cytokine assay enzyme-linked immuno sorbent assay ( ELISA ) , efficacy heart function improvement compare Qiliqiangxin capsule placebo standard treatment DCM .</brief_summary>
	<brief_title>Study Qiliqiangxin Capsule Treat Dilated Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Dilated Cardiomyopathy ( LVEF ≤ 45 % ) Secondary dilate cardiomyopathy ( ischemic cardiomyopathy , valvular cardiomyopathy , hyperthyroid cardiomyopathy , diabetic cardiomyopathy , anemia cardiomyopathy , etc . ) Coronary heart disease Rheumatic heart disease Pulmonary heart disease Continuous dysarteriotony : hypertension ( systolic blood pressure [ SBP ] ≥ 60mmHg/diastolic blood pressure [ DBP ] ≥ 100mmHg ) ; hypotension ( SBP &lt; 90mmHg/DBP &lt; 60mmHg ) Resting heart rate ≤ 50bpm Atrioventricular block patient without permanent pacemaker</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Immunomodulation</keyword>
</DOC>